文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.

作者信息

Das M L, Deb M, Karki B M S, Sarif M, Khanal B, Bhattacharya S K, Agrawal S, Koirala S

机构信息

Department of Microbiology, BP Koirala Institute of Health Sciences, Dharan, Nepal.

出版信息

Southeast Asian J Trop Med Public Health. 2007 Jul;38(4):619-25.


DOI:
PMID:17882997
Abstract

A recently developed nitrocellulose-based dipstick test, rK39, has been widely used for the diagnosis of kala-azar. In this study, we evaluated its use for the diagnosis of post kala-azar dermal leishmaniasis (PKDL). We also investigated the time taken by patients to develop PKDL after apparent cure of kala-azar (visceral leishmaniasis, VL) and the time taken by patients to come to the hospital after the appearance of symptoms of PKDL. A majority of patients developed the disease within three years after the apparent cure of kala-azar (KA). A majority of patients sought treatment within five years after the onset of PKDL. The amastigotes of Leishmania donovani bodies (LDBs) were demonstrated in 70, 20, and 20% of slit-skin smears (SSS) prepared, respectively, from nodular, papular, and macular forms. The presence of highest density (6+) LDBs in the SSS of 20% of nodular PKDL patients indicated that they may have acted as reservoir in the community. Other reservoirs are not known in Nepal. Only 8% cases were detected by aldehyde test. Although this test is obsolete it is still used in rural parts of Nepal. The dipstick (rK39) was 96% sensitive and 100% specific to diagnose PKDL. Its positive predictive value, negative predictive value, and diagnostic efficacy were 100, 91, and 97% respectively. Due to the advantage of cost compared with the direct agglutination test (DAT), and being easy to use and store in field conditions, rK39 is a good tool to diagnose PKDL in rural situations. All the PKDL patients were cured of the disease after treatment by SAG.

摘要

相似文献

[1]
Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.

Southeast Asian J Trop Med Public Health. 2007-7

[2]
Potential of direct agglutination test based on promastigote and amastigote antigens for serodiagnosis of post-kala-azar dermal leishmaniasis.

Clin Diagn Lab Immunol. 2005-10

[3]
Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis.

Trans R Soc Trop Med Hyg. 2008-2

[4]
Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.

J Clin Microbiol. 2005-3

[5]
Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.

J Med Microbiol. 1996-2

[6]
Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.

Indian J Med Res. 2005-12

[7]
Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.

Indian J Pathol Microbiol. 2003-4

[8]
Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.

Southeast Asian J Trop Med Public Health. 2003-3

[9]
Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

BMC Public Health. 2015-10-26

[10]
Serodiagnosis of leishmaniasis.

Crit Rev Microbiol. 1995

引用本文的文献

[1]
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.

PLoS Negl Trop Dis. 2024-4

[2]
Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal.

PLoS Negl Trop Dis. 2023-11

[3]
Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.

Front Immunol. 2023

[4]
Molecular Tracking of the Parasite.

Front Cell Infect Microbiol. 2021

[5]
Post kala-azar dermal leishmaniasis: A threat to elimination program.

PLoS Negl Trop Dis. 2020-7-2

[6]
The role of case proximity in transmission of visceral leishmaniasis in a highly endemic village in Bangladesh.

PLoS Negl Trop Dis. 2018-10-8

[7]
Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.

PLoS Negl Trop Dis. 2016-8-4

[8]
Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL).

J Trop Med. 2013-7-9

[9]
Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010).

PLoS Negl Trop Dis. 2011-12-20

[10]
Diagnosis of visceral leishmaniasis: developments over the last decade.

Parasitol Res. 2011-11-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索